Haifeng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Haifeng Wang has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Bi-Ming He
Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publications Biming He
Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publications- Hai Zhou
Urology
2 shared publications Peixuan Wu
Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publications- Qiwei Yang
Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, People's Republic of China
2 shared publications Rucheng Yan
Department of Urology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China
2 shared publications
Latest Publications
- Open Access
A polysynaptic hypothalamus–pelvic ganglion circuit regulates prostate tumor growth via WNT3A
Brain – tumor communication is increasingly recognized. Peripheral autonomic nerves regulate prostate cancer progression, yet how the brain influences local nerve–tumor interactions remains unclear. We identify a polysynaptic circuit linking the hypothalamic paraventricular nucleus (PVN), dorsal motor nucleus of the vagus (DMV), major pelvic ganglion (MPG) and prostate tumor in mice. Although both nuclei were activated during tumor growth, PVN activity restrained, whereas DMV activity promoted tumor growth. MPG ablation abolished DMV-induced tumor promotion. Combining LMD with Smart-seq2 revealed transcriptional remodeling and increased Wnt3a expression in tumor-innervating, activated MPG neurons under upstream neural control. MPG explants released WNT3A, whose neutralization suppressed explant-induced cancer-cell proliferation. Together, our findings identify a polysynaptic PVN–DMV–MPG circuit that regulates prostate tumor growth and implicate WNT3A as a mediator of the pro-tumor effects of the MPG, highlighting the therapeutic potential of targeting the neural circuit and downstream molecular pathway.
Open AccessA polysynaptic hypothalamus–pelvic ganglion circuit regulates prostate tumor growth via WNT3A
Brain – tumor communication is increasingly recognized. Peripheral autonomic nerves regulate prostate cancer progression, yet how the brain influences local nerve–tumor interactions remains unclear. We identify a polysynaptic circuit linking the hypothalamic paraventricular nucleus (PVN), dorsal motor nucleus of the vagus (DMV), major pelvic ganglion (MPG) and prostate tumor in mice. Although both nuclei were activated during tumor growth, PVN activity restrained, whereas DMV activity promoted tumor growth. MPG ablation abolished DMV-induced tumor promotion. Combining LMD with Smart-seq2 revealed transcriptional remodeling and increased Wnt3a expression in tumor-innervating, activated MPG neurons under upstream neural control. MPG explants released WNT3A, whose neutralization suppressed explant-induced cancer-cell proliferation. Together, our findings identify a polysynaptic PVN–DMV–MPG circuit that regulates prostate tumor growth and implicate WNT3A as a mediator of the pro-tumor effects of the MPG, highlighting the therapeutic potential of targeting the neural circuit and downstream molecular pathway.
- 3 July 2026
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 233
Dissection and Isolation of Mouse Dorsal Root Ganglia
Dorsal root ganglia (DRG), which contain the cell bodies of primary sensory neurons, serve as critical relay structures for the transmission of sensory signals from peripheral tissues to the spinal cord. They play essential roles in studies of pain, nerve injury, and neurodegenerative diseases. The acquisition of intact DRG tissue is crucial for investigating the functional properties, molecular expression, and pathological alterations of sensory neurons. However, due to their small size and deep location within the vertebral canal, accurate identification and isolation of DRG present significant technical challenges. In this study, we developed a standardized protocol for the isolation of mouse DRG. This method provides a detailed description of the anatomical localization of DRG, exposure of the vertebral canal, and the key steps involved in ganglion isolation. The entire procedure is illustrated with representative images and video recordings. This approach supports the acquisition of structurally intact DRG with anatomical guidance for segmental identification and is suitable for H&E staining and immunofluorescence analysis. Compared with previous DRG dissection methods, this method allows standardized recovery of segmentally identified ganglia, provides intuitive anatomical guidance for novice users, and reduces procedural tissue injury.
- 3 July 2026
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 233
Dissection and Isolation of Mouse Dorsal Root Ganglia
Dorsal root ganglia (DRG), which contain the cell bodies of primary sensory neurons, serve as critical relay structures for the transmission of sensory signals from peripheral tissues to the spinal cord. They play essential roles in studies of pain, nerve injury, and neurodegenerative diseases. The acquisition of intact DRG tissue is crucial for investigating the functional properties, molecular expression, and pathological alterations of sensory neurons. However, due to their small size and deep location within the vertebral canal, accurate identification and isolation of DRG present significant technical challenges. In this study, we developed a standardized protocol for the isolation of mouse DRG. This method provides a detailed description of the anatomical localization of DRG, exposure of the vertebral canal, and the key steps involved in ganglion isolation. The entire procedure is illustrated with representative images and video recordings. This approach supports the acquisition of structurally intact DRG with anatomical guidance for segmental identification and is suitable for H&E staining and immunofluorescence analysis. Compared with previous DRG dissection methods, this method allows standardized recovery of segmentally identified ganglia, provides intuitive anatomical guidance for novice users, and reduces procedural tissue injury.
- Open Access
- 9 April 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Melittin enhances PD-L1 blockade in prostate cancer by inhibiting M2 macrophage polarization and recruitment
The immunosuppressive tumor microenvironment (TME) limits the efficacy of immunotherapy in prostate cancer treatment. This study aims to investigate how me
- 9 April 2026
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 24 (1)
Open AccessMelittin enhances PD-L1 blockade in prostate cancer by inhibiting M2 macrophage polarization and recruitment
The immunosuppressive tumor microenvironment (TME) limits the efficacy of immunotherapy in prostate cancer treatment. This study aims to investigate how me
- Open Access
- 21 September 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (1) , 87-94
Diagnostic capability of 18F-PSMA PET-MRI and pelvic MRI plus bone scan in treatment-naive prostate cancer: a single-center paired validating confirmatory study
Background: Radical prostatectomy with pelvic lymph node dissection for the treatment of high-risk localized prostate cancer (PCa) results in long-term benefits in selected patients. But insufficient sensitivity of conventional examinations which are pelvic MRI and bone scan, limits the diagnosis of bone and lymph node metastasis of PCa. This affects the surgical management strategy of a large number of patients. The purpose of this study was to investigate whether 18F-prostate-specific membrane antigen (PSMA) PET-MRI could improve the clinical detection of PCa metastases compared with the conventional pelvic MRI plus bone scan. Materials and methods: From April 2020 to April 2023, we prospectively enroled 472 patients with histologically proven PCa in our centre, and 120 patients underwent 18F-PSMA PET-MRI, multiparametric MRI, and bone scan before laparoscopic radical prostatectomy plus lymph node dissection. The accuracy of imaging results in detecting lymph node and bone metastatic lesions was compared between PSMA PET-MRI and MRI plus bone scan. Results: In diagnosing lymph node metastasis, PSMA PET-MRI had an area under the curve (AUC) of 0.844 (95% CI: 0.738–0.949, P < 0.001), sensitivity and specificity of 75% and 96%, which performed apparently better than MRI [AUC=0.615 (95% CI: 0.480–0.750, P=0.073)]. PSMA PET-MRI showed excellent expression in the diagnosis of bone metastases, with an AUC of 0.910 (95% CI: 0.840–0.981, P P =0.001) in bone scanning. PSMA PET-MRI also had higher sensitivity than bone scanning (90% vs. 43%), while lower specificity (92% vs. 97%). Conclusion: PSMA PET-MRI is superior to conventional imaging at diagnosing metastases in lymph nodes and bones in PCa and can provide a more accurate stagement.
- 21 September 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (1) , 87-94
Open AccessDiagnostic capability of 18F-PSMA PET-MRI and pelvic MRI plus bone scan in treatment-naive prostate cancer: a single-center paired validating confirmatory study
Background: Radical prostatectomy with pelvic lymph node dissection for the treatment of high-risk localized prostate cancer (PCa) results in long-term benefits in selected patients. But insufficient sensitivity of conventional examinations which are pelvic MRI and bone scan, limits the diagnosis of bone and lymph node metastasis of PCa. This affects the surgical management strategy of a large number of patients. The purpose of this study was to investigate whether 18F-prostate-specific membrane antigen (PSMA) PET-MRI could improve the clinical detection of PCa metastases compared with the conventional pelvic MRI plus bone scan. Materials and methods: From April 2020 to April 2023, we prospectively enroled 472 patients with histologically proven PCa in our centre, and 120 patients underwent 18F-PSMA PET-MRI, multiparametric MRI, and bone scan before laparoscopic radical prostatectomy plus lymph node dissection. The accuracy of imaging results in detecting lymph node and bone metastatic lesions was compared between PSMA PET-MRI and MRI plus bone scan. Results: In diagnosing lymph node metastasis, PSMA PET-MRI had an area under the curve (AUC) of 0.844 (95% CI: 0.738–0.949, P < 0.001), sensitivity and specificity of 75% and 96%, which performed apparently better than MRI [AUC=0.615 (95% CI: 0.480–0.750, P=0.073)]. PSMA PET-MRI showed excellent expression in the diagnosis of bone metastases, with an AUC of 0.910 (95% CI: 0.840–0.981, P P =0.001) in bone scanning. PSMA PET-MRI also had higher sensitivity than bone scanning (90% vs. 43%), while lower specificity (92% vs. 97%). Conclusion: PSMA PET-MRI is superior to conventional imaging at diagnosing metastases in lymph nodes and bones in PCa and can provide a more accurate stagement.
- Open Access
- 1 August 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (10) , 3061-3069
Association of biopsy core number and location with pain in patients undergoing a transperineal prostate biopsy under local anaesthesia: a secondary analysis of the APROPOS trial
Background: APROPOS was a multicentre, randomized, blinded trial focus on investigating the perineal nerve block versus the periprostatic block in pain control for men undergoing a transperineal prostate biopsy. In the analysis reported here, the authors aimed to evaluate the association of biopsy core count and location with pain outcomes in patients undergoing a transperineal prostate biopsy under local anesthesia. Methods: APROPOS was performed at six medical centers in China. Patients with suspected prostate cancer were randomized to receive either a perineal nerve block or a periprostatic block (1:1), followed by a transperineal prostate biopsy. The secondary analysis outcomes were the worst pain experienced during the prostate biopsy and postbiopsy pain at 1,6, and 24 h. Results: Between 12 August 2020 and 20 July 2022, a total of 192 patients were randomized in the original trial, and 188 were involved in this analysis, with 94 patients per group. Participants had a median (IQR) age of 68 (63–72) and a median (IQR) prostate volume of 42.51 (30.04–62.84). The patient population had a median (IQR) number of biopsy cores of 15 (12–17.50), and 26.06% of patients had a biopsy cores count of more than 15. After adjusting the baseline characteristics, the number of biopsy cores was associated with the worst pain during the biopsy procedure in both the perineal nerve block group (β 0.19, 95% CI: 0.12–0.26, Pβ 0.16, 95% CI: 0.07–0.24, P<0.001). A similar association was also evident for the postbiopsy pain at 1, 6, and 24 h. A lesser degree of pain in both groups at any time (r range −0.57 to −0.01 for both groups) was associated with biopsy cores from the peripheral zone of the middle gland, while other locations were associated with a higher degree of pain. In addition, the location of the biopsy core had less of an effect on pain during the biopsy (r range −0.01–0.25 for both groups) than it did on postbiopsy pain (r range −0.57–0.60 for both groups). Conclusions: In this secondary analysis of a randomized trial, biopsy core count and location were associated with pain in patients undergoing a transperineal prostate biopsy under local anesthesia. These results may be helpful for making clinical decisions about the anesthetic approach for scheduled transperineal prostate biopsies.
- 1 August 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 109 (10) , 3061-3069
Open AccessAssociation of biopsy core number and location with pain in patients undergoing a transperineal prostate biopsy under local anaesthesia: a secondary analysis of the APROPOS trial
Background: APROPOS was a multicentre, randomized, blinded trial focus on investigating the perineal nerve block versus the periprostatic block in pain control for men undergoing a transperineal prostate biopsy. In the analysis reported here, the authors aimed to evaluate the association of biopsy core count and location with pain outcomes in patients undergoing a transperineal prostate biopsy under local anesthesia. Methods: APROPOS was performed at six medical centers in China. Patients with suspected prostate cancer were randomized to receive either a perineal nerve block or a periprostatic block (1:1), followed by a transperineal prostate biopsy. The secondary analysis outcomes were the worst pain experienced during the prostate biopsy and postbiopsy pain at 1,6, and 24 h. Results: Between 12 August 2020 and 20 July 2022, a total of 192 patients were randomized in the original trial, and 188 were involved in this analysis, with 94 patients per group. Participants had a median (IQR) age of 68 (63–72) and a median (IQR) prostate volume of 42.51 (30.04–62.84). The patient population had a median (IQR) number of biopsy cores of 15 (12–17.50), and 26.06% of patients had a biopsy cores count of more than 15. After adjusting the baseline characteristics, the number of biopsy cores was associated with the worst pain during the biopsy procedure in both the perineal nerve block group (β 0.19, 95% CI: 0.12–0.26, Pβ 0.16, 95% CI: 0.07–0.24, P<0.001). A similar association was also evident for the postbiopsy pain at 1, 6, and 24 h. A lesser degree of pain in both groups at any time (r range −0.57 to −0.01 for both groups) was associated with biopsy cores from the peripheral zone of the middle gland, while other locations were associated with a higher degree of pain. In addition, the location of the biopsy core had less of an effect on pain during the biopsy (r range −0.01–0.25 for both groups) than it did on postbiopsy pain (r range −0.57–0.60 for both groups). Conclusions: In this secondary analysis of a randomized trial, biopsy core count and location were associated with pain in patients undergoing a transperineal prostate biopsy under local anesthesia. These results may be helpful for making clinical decisions about the anesthetic approach for scheduled transperineal prostate biopsies.
- Open Access
- 19 September 2019
- Published by Springer Nature in Research Square
The safety and efficacy of irreversible electroporation versus tamsulosin in the treatment of benign prostatic obstruction: study protocol and rationale for a randomized controlled trial
Background Though transurethral resection of the prostate is still considered to be the ‘‘gold standard’’ procedure for benign prostatic obstruction (BPO), the reported post-operative complication rate is not uncommon. The emerging of minimally invasive focal ablative therapies provide an alternative option for patients who are dissatisfied with medical treatment yet do not willing to take the interventional procedures. Irreversible electroporation (IRE) is a novel focal therapy which can accurately ablate the target tissues with minimum damage to the surrounding structures. The application of IRE in selected patients with prostate cancer has yielded promising results, but no report on BPO has been published. Methods/design This is a single-centered, prospective, randomized controlled trial to evaluate the effectiveness and safety of IRE in treating BPO compare with tamsulosin. We aim to recruit BPO patients who are currently taking tamsulosin but without absolute indications for surgical intervention. Eligible subjects will undergo a 3-day treatment free washout period, followed by baseline assessment. After randomized into IRE group and tamsulosin (0.2mg orally once daily) group, subjects will be followed-up for up to 24 months. The primary clinical outcome is the change in maximum flow rate from baseline at 6 months. Other assessments, including symptom questionnaires, ultrasound, prostatic specific antigen, prostate magnetic resonance image and pressure-flow study, will be carried out at different time points during follow-up. Any perception or patient-reported adverse events in both treatment arms will be documented. Data will be analyzed by a specialist who is blinded to the medical status and treatment modality in order to minimize the potential bias. Discussion This is the first randomized controlled trial evaluating the feasibility of IRE for the treatment of BPO. The outcomes of this study will provide high level of evidence to determine its true clinical value.
- 19 September 2019
- Published by Springer Nature in Research Square
Open AccessThe safety and efficacy of irreversible electroporation versus tamsulosin in the treatment of benign prostatic obstruction: study protocol and rationale for a randomized controlled trial
Background Though transurethral resection of the prostate is still considered to be the ‘‘gold standard’’ procedure for benign prostatic obstruction (BPO), the reported post-operative complication rate is not uncommon. The emerging of minimally invasive focal ablative therapies provide an alternative option for patients who are dissatisfied with medical treatment yet do not willing to take the interventional procedures. Irreversible electroporation (IRE) is a novel focal therapy which can accurately ablate the target tissues with minimum damage to the surrounding structures. The application of IRE in selected patients with prostate cancer has yielded promising results, but no report on BPO has been published. Methods/design This is a single-centered, prospective, randomized controlled trial to evaluate the effectiveness and safety of IRE in treating BPO compare with tamsulosin. We aim to recruit BPO patients who are currently taking tamsulosin but without absolute indications for surgical intervention. Eligible subjects will undergo a 3-day treatment free washout period, followed by baseline assessment. After randomized into IRE group and tamsulosin (0.2mg orally once daily) group, subjects will be followed-up for up to 24 months. The primary clinical outcome is the change in maximum flow rate from baseline at 6 months. Other assessments, including symptom questionnaires, ultrasound, prostatic specific antigen, prostate magnetic resonance image and pressure-flow study, will be carried out at different time points during follow-up. Any perception or patient-reported adverse events in both treatment arms will be documented. Data will be analyzed by a specialist who is blinded to the medical status and treatment modality in order to minimize the potential bias. Discussion This is the first randomized controlled trial evaluating the feasibility of IRE for the treatment of BPO. The outcomes of this study will provide high level of evidence to determine its true clinical value.
- Open Access
- 10 January 2017
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 16 (1) , 8
Non-rigid MR-TRUS image registration for image-guided prostate biopsy using correlation ratio-based mutual information
To improve the accuracy of ultrasound-guided biopsy of the prostate, the non-rigid registration of magnetic resonance (MR) images onto transrectal ultrasound (TRUS) images has gained increasing attention. Mutual information (MI) is a widely used similarity criterion in MR-TRUS image registration. However, the use of MI has been challenged because of intensity distortion, noise and down-sampling. Hence, we need to improve the MI measure to get better registration effect. We present a novel two-dimensional non-rigid MR-TRUS registration algorithm that uses correlation ratio-based mutual information (CRMI) as the similarity criterion. CRMI includes a functional mapping of intensity values on the basis of a generalized version of intensity class correspondence. We also analytically acquire the derivative of CRMI with respect to deformation parameters. Furthermore, we propose an improved stochastic gradient descent (ISGD) optimization method based on the Metropolis acceptance criteria to improve the global optimization ability and decrease the registration time. The performance of the proposed method is tested on synthetic images and 12 pairs of clinical prostate TRUS and MR images. By comparing label map registration frame (LMRF) and conditional mutual information (CMI), the proposed algorithm has a significant improvement in the average values of Hausdorff distance and target registration error. Although the average Dice Similarity coefficient is not significantly better than CMI, it still has a crucial increase over LMRF. The average computation time consumed by the proposed method is similar to LMRF, which is 16 times less than CMI. With more accurate matching performance and lower sensitivity to noise and down-sampling, the proposed algorithm of minimizing CRMI by ISGD is more robust and has the potential for use in aligning TRUS and MR images for needle biopsy.
- 10 January 2017
- Published by Springer Nature in BioMedical Engineering OnLine
- Vol. 16 (1) , 8
Open AccessNon-rigid MR-TRUS image registration for image-guided prostate biopsy using correlation ratio-based mutual information
To improve the accuracy of ultrasound-guided biopsy of the prostate, the non-rigid registration of magnetic resonance (MR) images onto transrectal ultrasound (TRUS) images has gained increasing attention. Mutual information (MI) is a widely used similarity criterion in MR-TRUS image registration. However, the use of MI has been challenged because of intensity distortion, noise and down-sampling. Hence, we need to improve the MI measure to get better registration effect. We present a novel two-dimensional non-rigid MR-TRUS registration algorithm that uses correlation ratio-based mutual information (CRMI) as the similarity criterion. CRMI includes a functional mapping of intensity values on the basis of a generalized version of intensity class correspondence. We also analytically acquire the derivative of CRMI with respect to deformation parameters. Furthermore, we propose an improved stochastic gradient descent (ISGD) optimization method based on the Metropolis acceptance criteria to improve the global optimization ability and decrease the registration time. The performance of the proposed method is tested on synthetic images and 12 pairs of clinical prostate TRUS and MR images. By comparing label map registration frame (LMRF) and conditional mutual information (CMI), the proposed algorithm has a significant improvement in the average values of Hausdorff distance and target registration error. Although the average Dice Similarity coefficient is not significantly better than CMI, it still has a crucial increase over LMRF. The average computation time consumed by the proposed method is similar to LMRF, which is 16 times less than CMI. With more accurate matching performance and lower sensitivity to noise and down-sampling, the proposed algorithm of minimizing CRMI by ISGD is more robust and has the potential for use in aligning TRUS and MR images for needle biopsy.